Solriamfetol for the treatment of daytime sleepiness in obstructive sleep apnea.

Abstract:

:Introduction: Obstructive sleep apnea (OSA) is highly prevalent and constitutes a major health hazard. Current pharmacotherapy is ineffective in correcting sleep-disordered breathing and is used adjunctively to address residual sleepiness. A new drug, solriamfetol, a selective norepinephrine-dopamine reuptake inhibitor, is the first drug of its class that is being considered by the US Food and Drug Administration (FDA) to treat excessive sleepiness in OSA and narcolepsy patients. Areas covered: This review covers drug chemistry, pharmacodynamics, pharmacokinetics, and metabolism of solriamfetol. Results of three Phase 3 trials, Treatment of OSA and Narcolepsy Excessive Sleepiness (TONES 3, 4, 5), relevant to OSA patients are summarized. Published abstracts/articles and a 2017 Jazz Investor Presentation provided data. Databases searched included PubMed, Google Scholar, Lexi-Comp, Scopus, Science, and Ovid. Expert commentary: Solriamfetol shows promise as adjunctive therapy in OSA. It is well tolerated and effective in reducing sleepiness and is an alternative to modafinil or armodafinil. Unlike stimulants like methylphenidate or dextroamphetamine, it does not have cardiac effects, rebound hypersomnia, or withdrawal effects.

journal_name

Expert Rev Respir Med

authors

Abad VC,Guilleminault C

doi

10.1080/17476348.2018.1541742

subject

Has Abstract

pub_date

2018-12-01 00:00:00

pages

1007-1019

issue

12

eissn

1747-6348

issn

1747-6356

journal_volume

12

pub_type

杂志文章,评审
  • Morning symptoms in COPD: a treatable yet often overlooked factor.

    abstract:INTRODUCTION:Chronic obstructive pulmonary disease (COPD) patients experience the morning as the worst period of the day. Nevertheless, morning symptoms are not mentioned in COPD guidelines. Areas covered: Different topics on morning symptoms are covered in this review to underline their importance: occurrence, tools f...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2017.1305894

    authors: van Buul AR,Kasteleyn MJ,Chavannes NH,Taube C

    更新日期:2017-04-01 00:00:00

  • Clinical management of pulmonary sarcoidosis.

    abstract::Sarcoidosis is a multisystem disease for which diagnosis relies on the integration of clinical, radiologic, laboratory, and pathologic information. Assessment of clinical features is an important part of the disease evaluation. Computer Tomography provides information not available on routine chest roentgenogram which...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2016.1164602

    authors: Zhou Y,Lower EE,Li H,Baughman RP

    更新日期:2016-01-01 00:00:00

  • The implication of telehealthcare in COPD management of China.

    abstract::Chronic obstructive pulmonary disease (COPD) is a very common disease all around the world and has become an increasing public health concern to the Chinese medical community. In the past decades, telehealthcare technology has become a good way to manage COPD but current evidence makes it hard to determine the effecti...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2013.838019

    authors: Lao X,Zhang J,Bai C

    更新日期:2013-10-01 00:00:00

  • Long-term oxygen therapy.

    abstract::Long-term oxygen therapy (LTOT) has been shown to reduce pulmonary hypertension and improve survival in patients with chronic obstructive pulmonary disease and resting hypoxemia (reduced arterial partial pressure of oxygen ≤55 mmHg). However, the benefit of its use for chronic pulmonary diseases other than chronic obs...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.12.69

    authors: Jindal SK,Agarwal R

    更新日期:2012-12-01 00:00:00

  • Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention.

    abstract::Premature infants are at substantial risk for a spectrum of morbidities that are gestational age dependent. Respiratory syncytial virus (RSV) infection is most common in the first two years of life with the highest burden in children aged <6 months. Preterm infants ≤35 weeks' gestation are handicapped by incomplete im...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2015.1098536

    authors: Abraha HY,Lanctôt KL,Paes B

    更新日期:2015-01-01 00:00:00

  • The long-lasting effects of the acute respiratory distress syndrome.

    abstract::Introduction: Acute respiratory distress syndrome (ARDS) is a severe form of acute lung injury common in critically ill patients and characterized by significant morbidity and mortality. It frequently manifests long-lasting effects beyond hospitalization, from cognitive impairment to physical weakness.Areas covered: S...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1080/17476348.2020.1743182

    authors: Mart MF,Ware LB

    更新日期:2020-06-01 00:00:00

  • Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease.

    abstract:INTRODUCTION:N-acetyl-l-cysteine (NAC), a derivative of the naturally occurring amino acid l-cysteine, is a mucolytic agent that may also act as an antioxidant by providing cysteine intracellularly for increased production of glutathione. It is also used for the treatment of acetaminophen overdose. Areas covered: The r...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2018.1495562

    authors: Calzetta L,Matera MG,Rogliani P,Cazzola M

    更新日期:2018-08-01 00:00:00

  • What is the importance of classifying Aspergillus disease in cystic fibrosis patients?

    abstract::Aspergillus species are commonly isolated from lower respiratory tract samples of patients with cystic fibrosis (CF) and markers of immunological sensation to Aspergillus are frequently encountered in this group of patients; however, the contribution of Aspergillus to CF lung disease outside of the typical complicatio...

    journal_title:Expert review of respiratory medicine

    pub_type: 社论

    doi:10.1586/17476348.2014.915751

    authors: Jones AM,Horsley A,Denning DW

    更新日期:2014-08-01 00:00:00

  • Smoking and nonsmoking asthma: differences in clinical outcome and pathogenesis.

    abstract::Cigarette smoking in asthma is frequently present and is associated with worsening of symptoms, accelerated lung-function decline, a higher frequency of hospital admissions, a higher degree of asthma severity, poorer asthma control and reduced responsiveness to corticosteroids. Furthermore, it is associated with reduc...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.10.85

    authors: Fattahi F,Hylkema MN,Melgert BN,Timens W,Postma DS,ten Hacken NH

    更新日期:2011-02-01 00:00:00

  • IL-17 in human asthma.

    abstract::Asthma is perceived as a heterogeneous disease with several clinical phenotypes and triggering factors. In general, cytokines from T-helper 2 cells are believed to be critical contributors of asthma. In recent years, IL-17, another T-helper lymphocyte-associated cytokine, has been put forward as another potentially im...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.12.12

    authors: Silverpil E,Lindén A

    更新日期:2012-04-01 00:00:00

  • Current and future molecular approaches in the diagnosis of cystic fibrosis.

    abstract:INTRODUCTION:Cystic Fibrosis is among the first diseases to have general population genetic screening tests and one of the most common indications of prenatal and preimplantation genetic diagnosis for single gene disorders. During the past twenty years, thanks to the evolution of diagnostic techniques, our knowledge of...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2018.1457438

    authors: Bergougnoux A,Taulan-Cadars M,Claustres M,Raynal C

    更新日期:2018-05-01 00:00:00

  • Recent advances in optical coherence tomography for the diagnoses of lung disorders.

    abstract::There have been many advances in the field of diagnostic and therapeutic pulmonary medicine in the past several years, with major progress in the field of imaging. Optical coherence tomography (OCT) is a high-resolution (micron level) imaging modality currently being advanced with the potential to image airway wall st...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.11.59

    authors: Hou R,Le T,Murgu SD,Chen Z,Brenner M

    更新日期:2011-10-01 00:00:00

  • Pathophysiology, management and treatment of smoke inhalation injury.

    abstract::Smoke inhalation injury continues to increase morbidity and mortality in burn patients in both the third world and industrialized countries. The lack of uniform criteria for the diagnosis and definition of smoke inhalation injury contributes to the fact that, despite extensive research, mortality rates have changed li...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1586/ERS.09.21

    authors: Rehberg S,Maybauer MO,Enkhbaatar P,Maybauer DM,Yamamoto Y,Traber DL

    更新日期:2009-06-01 00:00:00

  • Perspectives in adjuvant chemotherapy in NSCLC.

    abstract::In 2007 the long-term outcome of lung cancer is still disappointing, with a 5-year survival rate not exceeding 15%. However, small but significant improvements in survival times have been achieved in the last decade. This progress has been achieved through the improvement of surgical techniques and following the intro...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1586/17476348.1.1.99

    authors: Selvaggi G,Scagliotti GV

    更新日期:2007-08-01 00:00:00

  • Frailty in lung transplantation: a systematic review.

    abstract::Introduction: Lung transplantation is an effective treatment for certain types of end-stage lung disease. Frailty is a complex clinical syndrome associated with decreased physiological reserve and an increased risk for suboptimal health outcomes.Area covered: This article reviews the current literature on frailty in l...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1080/17476348.2020.1702527

    authors: Montgomery E,Macdonald PS,Newton PJ,Jha SR,Malouf M

    更新日期:2020-02-01 00:00:00

  • Addressing epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small cell lung cancer.

    abstract::Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have significantly improved the survival of patients with advanced non-small cell lung cancer (NSCLC) harboring EGFR activating mutations. However, nearly all EGFR-mutant NSCLC tumors eventually acquire resistance to the currently used EGFR-TKIs a...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2016.1164603

    authors: Noda S,Kanda S

    更新日期:2016-01-01 00:00:00

  • Methicillin-resistant Staphylococcus aureus pneumonia in adults.

    abstract::Methicillin-resistant Staphylococcus aureus (MRSA) has become one of the leading etiologies of nosocomial pneumonia as a result of an increase in staphylococcal infections caused by methicillin-resistant strains paired with extended ventilatory support of critically, and often, chronically ill patients. The prevalence...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2014.940323

    authors: Woods C,Colice G

    更新日期:2014-10-01 00:00:00

  • Pharmacological treatment of refractory breathlessness.

    abstract::Refractory breathlessness is one of the most common and devastating symptoms of advanced cardiorespiratory disease, both malignant and nonmalignant. In spite of increased interest in research in the last 20 years, there have been few significant advances in the palliation of this distressing condition. The most succes...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1586/17476348.3.1.21

    authors: Booth S,Bausewein C,Higginson I,Moosavi SH

    更新日期:2009-02-01 00:00:00

  • Pulmonary hypertension trials: how can we do better?

    abstract::Conducting clinical trials on pulmonary hypertension in the US and Western Europe has become increasingly difficult and costly because of many challenges. These include a limited patient population that makes recruitment difficult. Recruiting internationally has helped, but can add variability. The choice of end point...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1586/17476348.2015.1074040

    authors: Hill NS,Roberts K,Preston I

    更新日期:2015-10-01 00:00:00

  • Role of dendritic cells in the lung: in vitro models, animal models and human studies.

    abstract::Dendritic cells (DCs) are the most potent antigen-presenting cells in the human lung and are now recognized as crucial initiators of immune responses in general. They are arranged as sentinels in a dense surveillance network inside and below the epithelium of the airways and alveoli, where they are ideally situated to...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1586/17476348.2.2.215

    authors: Blank F,von Garnier C,Obregon C,Rothen-Rutishauser B,Gehr P,Nicod L

    更新日期:2008-04-01 00:00:00

  • Arformoterol tartrate in the treatment of COPD.

    abstract::Some basic scientific data suggest that (S)-enantiomers of beta(2)-agonists have different and sometimes opposing effects to (R)-enantiomers. These data may explain the paradoxical response of the airways to the repeated, chronic administration of racemic beta(2)-agonists. Therefore, it is possible that the use of (R)...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.10.16

    authors: Cazzola M,Hanania NA,Matera MG

    更新日期:2010-04-01 00:00:00

  • The role of desmosines as biomarkers for chronic obstructive pulmonary disease.

    abstract::Since chronic obstructive pulmonary disease (COPD) has a progressive and major impact on health management, many aspects of this disorder, including development of effective and reliable biomarkers to monitor disease progression, are under intensive investigation. A huge amount of data, accumulated over the years, hav...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.13.4

    authors: Iadarola P,Luisetti M

    更新日期:2013-04-01 00:00:00

  • Treatment response heterogeneity in asthma: the role of genetic variation.

    abstract:INTRODUCTION:Asthmatic patients show a large heterogeneity in response to asthma medication. Rapidly evolving genotyping technologies have led to the identification of various genetic variants associated with treatment outcomes. Areas covered: This review focuses on the current knowledge of genetic variants influencing...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2018.1403318

    authors: Vijverberg SJH,Farzan N,Slob EMA,Neerincx AH,Maitland-van der Zee AH

    更新日期:2018-01-01 00:00:00

  • Current challenges in the recognition, prevention and treatment of perioperative pulmonary atelectasis.

    abstract::Innovations in surgery have significantly increased the number of procedures performed every year. While more individuals benefit from better surgical techniques and technology, a larger group of patients previously deemed ineligible for surgery now undergo high-complexity surgical procedures. Despite continuous impro...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2015.996134

    authors: Restrepo RD,Braverman J

    更新日期:2015-02-01 00:00:00

  • Assessment and monitoring of cystic fibrosis lung disease in infants and young children.

    abstract::Chronic airway infection and inflammation are the hallmarks of cystic fibrosis (CF) lung disease. As these events occur early in life, it is critical to develop techniques for the assessment and monitoring of early-CF lung disease in infants and young children. In the last several years, there have been major advances...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1586/17476348.2.3.381

    authors: Ren CL

    更新日期:2008-06-01 00:00:00

  • Ultrasound in the management of pleural disease.

    abstract:INTRODUCTION:Pleural disease encompasses a large range of conditions, is a common presentation to the acute medical take and often requires comprehensive investigation and treatment. Ultrasound is well recognised as a useful investigative tool in pleural disease especially in the field of pleural effusion, pleural thic...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2017.1300531

    authors: Mercer RM,Psallidas I,Rahman NM

    更新日期:2017-04-01 00:00:00

  • Acute oxygen therapy: a cross-sectional study of prescribing practices at an English hospital immediately before COVID-19 pandemic.

    abstract:BACKGROUND:Approximately 14% of UK hospital in-patients receive supplemental oxygen therapy, only 57% have valid prescriptions. Oxygen must be optimally prescribed to ensure maximal therapeutic response whilst minimizing adverse outcomes (including fatality). This study investigates prescription compliance. METHODS:Al...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1080/17476348.2021.1826316

    authors: Barrett R,Catangui E,Scott R

    更新日期:2020-10-14 00:00:00

  • COPD updates: what's new in pathophysiology and management?

    abstract::The historic perspective that used to define chronic obstructive pulmonary disease has changed. As reviewed in this article, it is based on a better understanding of the underlying inflammatory airflow obstruction and a multidimensional classification, which mostly targets a subgroup called 'frequent exacerbators'. Cl...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2013.814392

    authors: Noujeim C,Bou-Khalil P

    更新日期:2013-08-01 00:00:00

  • Mometasone furoate/formoterol in the treatment of persistent asthma.

    abstract::Mometasone furoate and formoterol fumarate dihydrate (MF/F) administered via metered-dose inhaler with a dose counter is a new fixed-dose combination of an inhaled corticosteroid and a long-acting β2-agonist indicated for daily maintenance therapy in patients aged ≥12 years with persistent asthma. Randomized, controll...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.11.71

    authors: Berger WE

    更新日期:2011-12-01 00:00:00

  • Vitamin D and omega-3 polyunsaturated fatty acid supplementation in athletes with exercise-induced bronchoconstriction: a pilot study.

    abstract:OBJECTIVE:The aim of this pilot study was to determine the combined effect of vitamin D and omega-3 polyunsaturated fatty acid (PUFA) supplementation on airway function and inflammation in recreational athletes with exercise-induced bronchoconstriction (EIB). METHODS:Ten recreational athletes with EIB participated in ...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1586/17476348.2015.1036032

    authors: Price OJ,Hull JH,Howatson G,Robson-Ansley P,Ansley L

    更新日期:2015-06-01 00:00:00